Lakewood-Amedex Biotherapeutics, Inc.
LABT
$3.14
-$0.34-9.77%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.70K | 236.40K | 658.40K | 1.27M | 477.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 38.90K | 69.00K | 119.80K | 52.60K | 74.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 50.60K | 305.40K | 778.20K | 1.32M | 551.00K |
|
|
|||||
| Total Current Assets | 50.60K | 305.40K | 778.20K | 1.32M | 551.00K |
| Net Property, Plant & Equipment | 137.60K | 168.10K | 198.40K | 228.50K | 258.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.10K | 8.10K | 8.50K | 8.50K | 8.50K |
| Total Assets | 196.30K | 481.60K | 985.10K | 1.56M | 817.90K |
|
|
|||||
| Total Accounts Payable | 547.80K | 381.00K | 278.80K | 79.50K | 210.30K |
| Total Accrued Expenses | 733.80K | 404.80K | 283.60K | 444.30K | 238.30K |
| Short-term Debt | 1.63M | 1.50M | 1.50M | 1.50M | 200.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 121.00K | 119.30K | 117.60K | 115.90K | 114.20K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.03M | 2.41M | 2.18M | 2.14M | 762.80K |
|
|
|||||
| Total Current Liabilities | 3.03M | 2.41M | 2.18M | 2.14M | 762.80K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.63M | 1.50M | 1.50M | 1.50M | 200.00K |
| Capital Leases | 10.30K | 41.00K | 71.40K | 101.60K | 131.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.04M | 2.45M | 2.25M | 2.24M | 894.10K |
|
|
|||||
| Common Stock & APIC | 51.58M | 51.53M | 51.49M | 50.16M | 50.11M |
| Retained Earnings | -54.27M | -53.35M | -52.61M | -50.70M | -50.04M |
| Treasury Stock & Other | -150.00K | -150.00K | -150.00K | -150.00K | -150.00K |
| Total Common Equity | -2.84M | -1.97M | -1.27M | -686.30K | -79.30K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
|
|
|||||
| Total Common Equity | -2.84M | -1.97M | -1.27M | -686.30K | -79.30K |
| Total Preferred Equity | 3.00K | 3.00K | 3.00K | 3.00K | 3.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.84M | -1.96M | -1.27M | -683.30K | -76.20K |
|
|
|||||